Malin Parmar

Human foetal brain tissue as quality control when developing stem cells towards cell replacement therapy for neurological diseases.

M. Parmar, Jenny Nelander, S. Grealish, 2013, Neuroreport.

Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD.

H. Bjartmarz, A. Landau, B. Mattsson, 2023, Cell stem cell.

Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson’s disease, STEM-PD

H. Bjartmarz, A. Landau, B. Mattsson, 2022 .

The history and status of dopamine cell therapies for Parkinson's disease.

Malin Parmar, Roger A Barker, Anders Björklund, 2024, BioEssays : news and reviews in molecular, cellular and developmental biology.

Monosynaptic Tracing using Modified Rabies Virus Reveals Early and Extensive Circuit Integration of Human Embryonic Stem Cell-Derived Neurons

A. Heuer, Tiago Cardoso, A. Kirkeby, 2016 .